[FDMT] YoY Quarter Result on 30-Sep-2020 [#Q3]

Stock
[FDMT] 4D Molecular Therapeutics, Inc.
Announcement Date
29-Sep-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 48.31%
YoY- 53.03%
Quarter Report
FDMT's Result
FDMT's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 3 20,204 500 1,366 7,421 540 4,531 -70.44%
PBT -43,843 -10,256 -25,691 -22,239 -7,833 -16,675 -2,183 64.79%
Tax 0 -3,876 -1,599 -435 -4 -341 0 -
NP -43,843 -10,256 -24,092 -22,239 -7,833 -16,675 -2,183 64.79%
Tax Rate - - - - - - - -
Total Cost 43,846 30,460 24,592 23,605 15,254 17,215 6,713 36.68%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -1,461,433.33 -50.76 -4,818.40 -1,628.04 -105.55 -3,087.96 -48.17 457.59%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.79 -0.24 -0.74 -0.82 -0.36 -1.12 -0.43 10.65%
EPS Diluted -0.79 -0.24 -0.74 -0.82 -0.36 -1.12 -0.43 10.65%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.